Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.97
-0.65-8.53%
At close: -
$7.28
0.314.45%
After Hours: May 23, 6:32 PM EDT
Comments
Loading...
TransCode Therapeutics Stock Price, Quotes and Forecasts
RNAZNASDAQ
TransCode Therapeutics (RNAZ) Forecast
NewsEarningsTransCode Therapeutics (RNAZ) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
TransCode Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RNAZ | Benzinga
Explore TransCode Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNAZ.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy TransCode Therapeutics (RNAZ) stock?
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Who are TransCode Therapeutics (RNAZ) competitors?
Other companies in TransCode Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS) and Imunon (NASDAQ:IMNN).
What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?
TransCode Therapeutics has a consensus price target of $10.00.
What is the current price for TransCode Therapeutics (RNAZ)?
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $7.28 last updated May 23, 2025 at 6:32 PM EDT.
Does TransCode Therapeutics (RNAZ) pay a dividend?
There are no upcoming dividends for TransCode Therapeutics.
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.
Is TransCode Therapeutics (RNAZ) going to split?
There is no upcoming split for TransCode Therapeutics.
What sector and industry does TransCode Therapeutics (RNAZ) operate in?
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
